Skip to content

Added Value of Cone Beam CT Guidance to Electromagnetic Navigation Bronchoscopy for the Diagnosis of Pulmonary Nodule.

A Randomized Controlled Study Evaluating the Added Value of an Hybrid Room Equipped With a Cone Beam CT (CBCT) to Electromagnetic Navigation Bronchoscopy (ENB) for the Diagnosis of Pulmonary Nodule.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05257382
Enrollment
49
Registered
2022-02-25
Start date
2020-02-01
Completion date
2022-04-01
Last updated
2022-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Pulmonary Disease

Brief summary

A monocentric prospective and randomized trial aiming to compare the diagnostic yield and safety of electromagnetical-guided bronchoscopy (ENB) procedures coupled to trans-bronchial lung cryobiopsies for the diagnosis of pulmonary nodule when performed either in a standard bronchoscopy suite or in a hybrid room with CBCT guidance and the use of the CrossCountry technique as required.

Interventions

PROCEDUREENB followed by trans-bronchial biopsy and trans-bronchial cryobiopsy

After having performed the ENB procedure to reach the identified lung lesion, biopsies will be performed (six forceps trans-bronchial biopsies and one trans-bronchial lung cryobiopsy)

Sponsors

Erasme University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pulmonary nodule of maximum 30mm of largest diameter * Nodules can be either solid or subsolid (including GGO) without evidence of loco-regional or distant metastasis that could be biopsied, and no evidence for an infectious underlying disease. * A multidisciplinary discussion is performed for each case before considering its inclusion in the study in order to validate the indication of ENB-guided biopsy. Of note, any other endoscopic or trans-thoracic procedure should be tried before considering ENB if it could achieve the diagnosis according to the investigator's judgment.

Exclusion criteria

* Patient eligible for a direct surgical resection of the nodule * Other

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic yieldThrough study completion, an average of 1 yearThe primary outcome will be the comparison of the diagnostic yield obtained when ENB procedures will be performed on either the classical endoscopic suite or in the CBCT suite

Secondary

MeasureTime frameDescription
Rate of bleedingup to 1 month after the procedureBleeding will be scored as follows: score 0, when no bleeding occurs; score 1, when bleeding stops within five minutes either spontaneously or by inflation of a Fogarty balloon; score 2, when bleeding is prolonged more than five minutes or needs cold saline instillation; and score 3, when bleeding requires embolization, selective bronchial intubation, transfusion, admission in the intensive care unit, results in prolonged hospital stay, or patient's death.
Rate of pneumothoraxup to 1 month after the procedureOn the basis of control chest Xray performs after the endoscopic intervention. The need of chest drainage will also be recorded.
Duration of the interventionsUp to one day after the procedureThe total duration of the bronchoscope intervention will be recorded.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026